327 related articles for article (PubMed ID: 11331882)
21. Structure-activity studies on a library of potent calix[4]arene-based PDGF antagonists that inhibit PDGF-stimulated PDGFR tyrosine phosphorylation.
Zhou H; Wang DA; Baldini L; Ennis E; Jain R; Carie A; Sebti SM; Hamilton AD
Org Biomol Chem; 2006 Jun; 4(12):2376-86. PubMed ID: 16763682
[TBL] [Abstract][Full Text] [Related]
22. Platelet-derived growth factor-alpha receptor activation is required for human cytomegalovirus infection.
Soroceanu L; Akhavan A; Cobbs CS
Nature; 2008 Sep; 455(7211):391-5. PubMed ID: 18701889
[TBL] [Abstract][Full Text] [Related]
23. [Platelet- derived growth factor--the construction, role and it's receptors].
Mantur M; Koper O
Pol Merkur Lekarski; 2008 Feb; 24(140):173-6. PubMed ID: 18634279
[TBL] [Abstract][Full Text] [Related]
24. PDGF-A and PDGFR-alpha regulate tooth formation via autocrine mechanism during mandibular morphogenesis in vitro.
Chai Y; Bringas P; Mogharei A; Shuler CF; Slavkin HC
Dev Dyn; 1998 Dec; 213(4):500-11. PubMed ID: 9853970
[TBL] [Abstract][Full Text] [Related]
25. A new look at platelet-derived growth factor in renal disease.
Floege J; Eitner F; Alpers CE
J Am Soc Nephrol; 2008 Jan; 19(1):12-23. PubMed ID: 18077793
[TBL] [Abstract][Full Text] [Related]
26. PDGF-C is a new protease-activated ligand for the PDGF alpha-receptor.
Li X; Pontén A; Aase K; Karlsson L; Abramsson A; Uutela M; Bäckström G; Hellström M; Boström H; Li H; Soriano P; Betsholtz C; Heldin CH; Alitalo K; Ostman A; Eriksson U
Nat Cell Biol; 2000 May; 2(5):302-9. PubMed ID: 10806482
[TBL] [Abstract][Full Text] [Related]
27. Expression of platelet-derived growth factors C and D in the synovial membrane of patients with rheumatoid arthritis and osteoarthritis.
Pohlers D; Huber R; Ukena B; Kinne RW
Arthritis Rheum; 2006 Mar; 54(3):788-94. PubMed ID: 16508943
[TBL] [Abstract][Full Text] [Related]
28. A specific requirement for PDGF-C in palate formation and PDGFR-alpha signaling.
Ding H; Wu X; Boström H; Kim I; Wong N; Tsoi B; O'Rourke M; Koh GY; Soriano P; Betsholtz C; Hart TC; Marazita ML; Field LL; Tam PP; Nagy A
Nat Genet; 2004 Oct; 36(10):1111-6. PubMed ID: 15361870
[TBL] [Abstract][Full Text] [Related]
29. Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis.
Baroni SS; Santillo M; Bevilacqua F; Luchetti M; Spadoni T; Mancini M; Fraticelli P; Sambo P; Funaro A; Kazlauskas A; Avvedimento EV; Gabrielli A
N Engl J Med; 2006 Jun; 354(25):2667-76. PubMed ID: 16790699
[TBL] [Abstract][Full Text] [Related]
30. PDGF C is a selective alpha platelet-derived growth factor receptor agonist that is highly expressed in platelet alpha granules and vascular smooth muscle.
Fang L; Yan Y; Komuves LG; Yonkovich S; Sullivan CM; Stringer B; Galbraith S; Lokker NA; Hwang SS; Nurden P; Phillips DR; Giese NA
Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):787-92. PubMed ID: 15061151
[TBL] [Abstract][Full Text] [Related]
31. Oncogenic derivatives of platelet-derived growth factor receptors.
Jones AV; Cross NC
Cell Mol Life Sci; 2004 Dec; 61(23):2912-23. PubMed ID: 15583853
[TBL] [Abstract][Full Text] [Related]
32. PDGF-A/PDGF alpha-receptor signaling is required for lung growth and the formation of alveoli but not for early lung branching morphogenesis.
Boström H; Gritli-Linde A; Betsholtz C
Dev Dyn; 2002 Jan; 223(1):155-62. PubMed ID: 11803579
[TBL] [Abstract][Full Text] [Related]
33. The uPA/uPAR system regulates the bioavailability of PDGF-DD: implications for tumour growth.
Ehnman M; Li H; Fredriksson L; Pietras K; Eriksson U
Oncogene; 2009 Jan; 28(4):534-44. PubMed ID: 18997817
[TBL] [Abstract][Full Text] [Related]
34. The alpha PDGFR tyrosine kinase mediates locomotion of two different cell types through chemotaxis and chemokinesis.
Uren A; Yu JC; Gholami NS; Pierce JH; Heidaran MA
Biochem Biophys Res Commun; 1994 Oct; 204(2):628-34. PubMed ID: 7980524
[TBL] [Abstract][Full Text] [Related]
35. Caveolin is an inhibitor of platelet-derived growth factor receptor signaling.
Yamamoto M; Toya Y; Jensen RA; Ishikawa Y
Exp Cell Res; 1999 Mar; 247(2):380-8. PubMed ID: 10066366
[TBL] [Abstract][Full Text] [Related]
36. Constitutive diffuse activation of phosphoinositide 3-kinase at the plasma membrane by v-Src suppresses the chemotactic response to PDGF by abrogating the polarity of PDGF receptor signalling.
Platek A; Vassilev VS; de Diesbach P; Tyteca D; Mettlen M; Courtoy PJ
Exp Cell Res; 2007 Apr; 313(6):1090-105. PubMed ID: 17335807
[TBL] [Abstract][Full Text] [Related]
37. Platelet-derived growth factor (PDGF) receptor-alpha-activated c-Jun NH2-terminal kinase-1 is critical for PDGF-induced p21WAF1/CIP1 promoter activity independent of p53.
Yu J; Liu XW; Kim HR
J Biol Chem; 2003 Dec; 278(49):49582-8. PubMed ID: 14506245
[TBL] [Abstract][Full Text] [Related]
38. Molecular cloning of SCDGF-B, a novel growth factor homologous to SCDGF/PDGF-C/fallotein.
Hamada T; Ui-Tei K; Imaki J; Miyata Y
Biochem Biophys Res Commun; 2001 Jan; 280(3):733-7. PubMed ID: 11162582
[TBL] [Abstract][Full Text] [Related]
39. The function of platelet-derived growth factor in the differentiation of mouse tongue striated muscle.
Suzuki E; Aoyama K; Fukui T; Nakamura Y; Yamane A
Orthod Craniofac Res; 2012 Feb; 15(1):39-51. PubMed ID: 22264326
[TBL] [Abstract][Full Text] [Related]
40. Alanine mutagenesis of conserved residues in the platelet-derived growth factor family: identification of residues necessary for dimerization and transformation.
Maher DW; Strawn LM; Donoghue DJ
Oncogene; 1993 Mar; 8(3):533-41. PubMed ID: 8437840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
